首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

British Journal Of Pharmacology

British Journal Of Pharmacology杂志,由Wiley-Blackwell出版,于1968年创刊,Semimonthly,出版语言English,ISSN:0007-1188,E-ISSN:1476-5381。

投稿咨询
British Journal Of Pharmacology
British Journal Of Pharmacology
British Journal Of Pharmacology
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
2区
影响因子
7.5
CiteScore
13.5
期刊收录
SCI、SCIE

British Journal Of Pharmacology(中文译名:《英国药理学杂志》),ISSN:0007-1188,EISSN:1476-5381,是Wiley-Blackwell出版的国际性学术期刊,创刊于1968年,以Semimonthly形式稳定发行,2026年总发文量约313篇。该刊采用非OA开放访问,学科归属为医学 - 药学。该刊是医学、药学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达7.5,2025年期刊CiteScore为13.5,2025年期刊自引率约18.7%,在中科院期刊分区体系中位列医学大类2区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。British Journal Of Pharmacology长期聚焦医学、药学及相关产业的技术应用前沿,平均审稿周期约2.0个月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,EnglandUSA、CHINA MAINLAND、GERMANY (FED REP GER)、Australia、Italy、Scotland等为核心发文国家与地区;UNIVERSITY OF LONDONUNIVERSITY OF NOTTINGHAM、UNIVERSITY OF CALIFORNIA SYSTEM、INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)、IMPERIAL COLLEGE LONDON、MONASH UNIVERSITY、CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
PHARMACOLOGY & PHARMACY 药学
1区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 27 / 356

92.6

学科:PHARMACOLOGY & PHARMACY SCIE Q1 21 / 356

94.24

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 18 / 352

95

学科:PHARMACOLOGY & PHARMACY SCIE Q1 15 / 353

95.89


中国学者近期发文

1
The deubiquitinase YOD1 in cardiomyocytes mediates septic cardiomyopathy by deubiquitinating and thus stabilizing the NLRP3 inflammasom

Author:Zheng, Zhaozheng; Liao, Yingjie; Jiang, Yucheng; Jia, Zhihan; Lin, Wante; Xu, Diyun; Jin, Yanhong; Zhao, Qingqing; Wu, Gaojun; Ye, Bozhi; Liang, Guang

Journal: BRITISH JOURNAL OF PHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1111/bph.70419

2
Cordycepin alleviates ischaemic brain injury by suppressing microglia-induced neuroinflammation via regulating the Notch1 signalling pathwa

Author:Li, Xing; Zhan, Gao-feng; Zhang, Xue; Zhao, Yi-lin; Mao, Meng; Xia, Qian

Journal: BRITISH JOURNAL OF PHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1111/bph.70426

3
Ginsenoside compound K up-regulates β-subunits of long-chain L-3-hydroxyacyl-CoA (HADHB) to promote fatty acid oxidation recovery and improve the balance of macrophage polarization in mice with ulcerative coliti

Author:Liu, Lili; Liu, Mengxue; Zhang, Yanqiu; Zeng, Xuran; Wang, Qiao; Chen, Jingyu

Journal: BRITISH JOURNAL OF PHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1111/bph.70428

4
Astragaloside II alleviates cardiac hypertrophy by targeting aminoacylase-1: a novel mechanism via the β-catenin/transcription factor 4/ubiquitin C-terminal hydrolase L1 axi

Author:Lin, Yangyang; Gong, Shuaishuai; Lai, Qiong; Lin, Pingping; Sun, Minhui; Yu, Boyang; Kou, Junping; Gao, Lan; Li, Fang

Journal: BRITISH JOURNAL OF PHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1111/bph.70416

5
Revisiting the GRK2-NOX4 axis in cisplatin-induced nephrotoxicit

Author:Xue, Cheng

Journal: BRITISH JOURNAL OF PHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1111/bph.70462

6
Study on the mechanism of the combined effects of high shear stress and antiplatelet drug on platelet haemostatic functio

Author:Wang, Hongyu; Li, Yuan; Jia, Jinze; Xi, Yifeng; Zhang, Xianghao; Zhang, Wenbo; Chen, Zengsheng

Journal: BRITISH JOURNAL OF PHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1111/bph.70433

7
A covalent molecular glue hijacks the E3 ligase MKRN2 to degrade the ribosomal protein RPS7 and induce synthetic lethality in p53-deficient NSCLC cell

Author:Pan, Yuqi; Hua, Shengjie; Yang, Ruolan; He, Qinman; Xu, Yan; Jiang, Zeyu; Gong, Xiaoyang; Zhang, Shurui; Wang, Xiao; Yu, Hongli; Wu, Hao; Wen, Hongmei; Wang, Pin; Hang, Bo; Wang, Xinzhi

Journal: BRITISH JOURNAL OF PHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1111/bph.70434

8
Bortezomib promotes neutrophil-mediated bacterial clearance in sepsis by inhibiting plasmablast activatio

Author:Wang, Jianyao; Yao, Qiqi; He, Yuxin; Fu, Wei; Liu, Dongjie; Wang, Xiao; Wang, Cheng; Xu, Tongxiang; Yu, Xinping; Zhang, Teng; Ma, Tao

Journal: BRITISH JOURNAL OF PHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1111/bph.70450

9
Reply to the Letter to the Editor from Chen Xue entitled Revisiting the GRK2-NOX4 axis in cisplatin-induced nephrotoxicit

Author:Duan, Fei; Xu, Bingfa; Wei, Wei; Wang, Chun

Journal: BRITISH JOURNAL OF PHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1111/bph.70482

10
Sodium valproate induces pancreatic injury by disruption of one-carbon metabolis

Author:Cai, Wenhao; Wu, Di; Li, Yuying; Chvanov, Michael; Awais, Muhammad; Forootan, Shiva Seyed; Meng, Xiaoli; Latawiec, Diane; Brown, Joseph P.; Li, Ziyu; He, Wenhua; Evans, Anthony; Mukherjee, Rajarshi; Szatmary, Peter; Criddle, David N.; Goldring, Chris; Huang, Wei; Xia, Qing; Sutton, Robert

Journal: BRITISH JOURNAL OF PHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1111/bph.70429


在线咨询

British Journal Of Pharmacology

国际简称:BRIT J PHARMACOL参考译名:英国药理学杂志

年发文量:313 CiteScore:13.5 是否预警:否 Gold OA文章占比:50.48% 研究类文章占比:85.30%

杂志社联系方式:WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148

British Journal Of Pharmacology